ICD-9 Code |
|
ICD-10 Code |
ICD-10 Description |
995.29 |
|
T36.0X5A |
Adverse effect of penicillins, initial encounter |
T36.1X5A |
Adverse effect of cephalospor/oth beta-lactm antibiot, init |
T36.2X5A |
Adverse effect of chloramphenicol group, initial encounter |
T36.3X5A |
Adverse effect of macrolides, initial encounter |
T36.4X5A |
Adverse effect of tetracyclines, initial encounter |
T36.5X5A |
Adverse effect of aminoglycosides, initial encounter |
T36.6X5A |
Adverse effect of rifampicins, initial encounter |
T36.7X5A |
Adverse effect of antifungal antibiotics, sys used, init |
T36.8X5A |
Adverse effect of other systemic antibiotics, init encntr |
T36.95XA |
Adverse effect of unsp systemic antibiotic, init encntr |
T37.0X5A |
Adverse effect of sulfonamides, initial encounter |
T37.1X5A |
Adverse effect of antimycobacterial drugs, initial encounter |
T37.2X5A |
Advrs effect of antimalari/drugs acting on bld protzoa, init |
T37.3X5A |
Adverse effect of other antiprotozoal drugs, init encntr |
T37.4X5A |
Adverse effect of anthelminthics, initial encounter |
T37.5X5A |
Adverse effect of antiviral drugs, initial encounter |
T37.8X5A |
Adverse effect of systemic anti-infect/parasit, init |
T37.95XA |
Advrs effect of unsp sys anti-infect and antiparasitic, init |
T38.0X5A |
Adverse effect of glucocort/synth analog, init |
T38.1X5A |
Adverse effect of thyroid hormones and substitutes, init |
T38.2X5A |
Adverse effect of antithyroid drugs, initial encounter |
T38.4X5A |
Adverse effect of oral contraceptives, initial encounter |
T38.5X5A |
Adverse effect of oth estrogens and progestogens, init |
T38.6X5A |
Adverse effect of antigonadtr/antiestr/antiandrg, NEC, init |
T38.7X5A |
Adverse effect of androgens and anabolic congeners, init |
T38.805A |
Adverse effect of unsp hormones and synthetic sub, init |
T38.815A |
Adverse effect of anterior pituitary hormones, init encntr |
T38.895A |
Adverse effect of hormones and synthetic substitutes, init |
T38.905A |
Adverse effect of unsp hormone antagonists, init encntr |
T38.995A |
Adverse effect of other hormone antagonists, init encntr |
T39.015A |
Adverse effect of aspirin, initial encounter |
T39.095A |
Adverse effect of salicylates, initial encounter |
T39.1X5A |
Adverse effect of 4-Aminophenol derivatives, init encntr |
T39.2X5A |
Adverse effect of pyrazolone derivatives, initial encounter |
T39.315A |
Adverse effect of propionic acid derivatives, init encntr |
T39.395A |
Adverse effect of nonsteroidal anti-inflammatory drugs, init |
T39.4X5A |
Adverse effect of antirheumatics, NEC, init |
T39.8X5A |
Adverse effect of nonopioid analges/antipyret, NEC, init |
T39.95XA |
Adverse effect of unsp nonopi analgs/antipyr/antirheu, init |
T40.0X5A |
Adverse effect of opium, initial encounter |
T40.2X5A |
Adverse effect of other opioids, initial encounter |
T40.3X5A |
Adverse effect of methadone, initial encounter |
T40.4X5A |
Adverse effect of other synthetic narcotics, init encntr |
T40.5X5A |
Adverse effect of cocaine, initial encounter |
T40.605A |
Adverse effect of unspecified narcotics, initial encounter |
T40.695A |
Adverse effect of other narcotics, initial encounter |
T40.7X5A |
Adverse effect of cannabis (derivatives), initial encounter |
T40.905A |
Adverse effect of unspecified psychodysleptics, init encntr |
T40.995A |
Adverse effect of other psychodysleptics, initial encounter |
T41.5X5A |
Adverse effect of therapeutic gases, initial encounter |
T42.0X5A |
Adverse effect of hydantoin derivatives, initial encounter |
T42.1X5A |
Adverse effect of iminostilbenes, initial encounter |
T42.2X5A |
Adverse effect of succinimides and oxazolidinediones, init |
T42.3X5A |
Adverse effect of barbiturates, initial encounter |
T42.4X5A |
Adverse effect of benzodiazepines, initial encounter |
T42.5X5A |
Adverse effect of mixed antiepileptics, initial encounter |
T42.6X5A |
Adverse effect of antiepileptic and sed-hypntc drugs, init |
T42.75XA |
Adverse effect of unsp antieplptc and sed-hypntc drugs, init |
T42.8X5A |
Adverse effect of antiparkns drug/centr musc-tone depr, init |
T43.015A |
Adverse effect of tricyclic antidepressants, init encntr |
T43.025A |
Adverse effect of tetracyclic antidepressants, init encntr |
T43.1X5A |
Adverse effect of MAO inhib antidepressants, init |
T43.205A |
Adverse effect of unspecified antidepressants, init encntr |
T43.215A |
Advrs effect of slctv seroton/norepineph reup inhibtr, init |
T43.225A |
Adverse effect of selective serotonin reuptake inhibtr, init |
T43.295A |
Adverse effect of other antidepressants, initial encounter |
T43.3X5A |
Adverse effect of phenothiazine antipsychot/neurolept, init |
T43.4X5A |
Adverse effect of butyrophen/thiothixen neuroleptics, init |
T43.505A |
Adverse effect of unsp antipsychotics and neuroleptics, init |
T43.595A |
Adverse effect of oth antipsychotics and neuroleptics, init |
T43.605A |
Adverse effect of unspecified psychostimulants, init encntr |
T43.615A |
Adverse effect of caffeine, initial encounter |
T43.625A |
Adverse effect of amphetamines, initial encounter |
T43.635A |
Adverse effect of methylphenidate, initial encounter |
T43.695A |
Adverse effect of other psychostimulants, initial encounter |
T43.8X5A |
Adverse effect of other psychotropic drugs, init encntr |
T43.95XA |
Adverse effect of unspecified psychotropic drug, init encntr |
T44.0X5A |
Adverse effect of anticholinesterase agents, init encntr |
T44.1X5A |
Adverse effect of other parasympathomimetics, init encntr |
T44.2X5A |
Adverse effect of ganglionic blocking drugs, init encntr |
T44.3X5A |
Adverse effect of parasympatholytics and spasmolytics, init |
T44.4X5A |
Adverse effect of predom alpha-adrenocpt agonists, init |
T44.5X5A |
Adverse effect of predom beta-adrenocpt agonists, init |
T44.6X5A |
Adverse effect of alpha-adrenoreceptor antagonists, init |
T44.7X5A |
Adverse effect of beta-adrenoreceptor antagonists, init |
T44.8X5A |
Adverse effect of centr-acting/adren-neurn-block agnt, init |
T44.905A |
Advrs effect of unsp drugs aff the autonm nervous sys, init |
T45.0X5A |
Adverse effect of antiallergic and antiemetic drugs, init |
T45.1X5A |
Adverse effect of antineoplastic and immunosup drugs, init |
T45.2X5A |
Adverse effect of vitamins, initial encounter |
T45.3X5A |
Adverse effect of enzymes, initial encounter |
T45.4X5A |
Adverse effect of iron and its compounds, initial encounter |
T45.515A |
Adverse effect of anticoagulants, initial encounter |
T45.525A |
Adverse effect of antithrombotic drugs, initial encounter |
T45.605A |
Adverse effect of unsp fibrinolysis-affecting drugs, init |
T45.615A |
Adverse effect of thrombolytic drugs, initial encounter |
T45.625A |
Adverse effect of hemostatic drug, initial encounter |
T45.695A |
Adverse effect of oth fibrinolysis-affecting drugs, init |
T45.7X5A |
Adverse effect of anticoag antag, vit K and oth coag, init |
T45.8X5A |
Adverse effect of prim systemic and hematolog agents, init |
T45.95XA |
Adverse effect of unsp prim sys and hematolog agent, init |
T46.0X5A |
Adverse effect of cardi-stim glycos/drug simlar act, init |
T46.1X5A |
Adverse effect of calcium-channel blockers, init encntr |
T46.2X5A |
Adverse effect of other antidysrhythmic drugs, init encntr |
T46.3X5A |
Adverse effect of coronary vasodilators, initial encounter |
T46.4X5A |
Adverse effect of angiotens-convert-enzyme inhibitors, init |
T46.5X5A |
Adverse effect of other antihypertensive drugs, init encntr |
T46.6X5A |
Adverse effect of antihyperlip and antiarterio drugs, init |
T46.7X5A |
Adverse effect of peripheral vasodilators, initial encounter |
T46.8X5A |
Adverse effect of antivaric drugs, inc scler agents, init |
T46.905A |
Adverse effect of unsp agents aff the cardiovasc sys, init |
T46.995A |
Adverse effect of agents aff the cardiovascular sys, init |
T47.0X5A |
Adverse effect of histamine H2-receptor blockers, init |
T47.1X5A |
Adverse effect of antacids and anti-gstrc-sec drugs, init |
T47.2X5A |
Adverse effect of stimulant laxatives, initial encounter |
T47.3X5A |
Adverse effect of saline and osmotic laxatives, init encntr |
T47.4X5A |
Adverse effect of other laxatives, initial encounter |
T47.5X5A |
Adverse effect of digestants, initial encounter |
T47.6X5A |
Adverse effect of antidiarrheal drugs, initial encounter |
T47.7X5A |
Adverse effect of emetics, initial encounter |
T47.8X5A |
Adverse effect of agents primarily affecting GI sys, init |
T47.95XA |
Adverse effect of unsp agents aff the GI sys, init |
T48.0X5A |
Adverse effect of oxytocic drugs, initial encounter |
T48.1X5A |
Adverse effect of skeletal muscle relaxants, init encntr |
T48.205A |
Adverse effect of unsp drugs acting on muscles, init encntr |
T48.295A |
Adverse effect of other drugs acting on muscles, init encntr |
T48.3X5A |
Adverse effect of antitussives, initial encounter |
T48.4X5A |
Adverse effect of expectorants, initial encounter |
T48.5X5A |
Adverse effect of other anti-common-cold drugs, init encntr |
T48.6X5A |
Adverse effect of antiasthmatics, initial encounter |
T48.905A |
Advrs effect of unsp agents prim act on the resp sys, init |
T48.995A |
Adverse effect of agents prim acting on the resp sys, init |
T49.0X5A |
Adverse effect of local antifung/infect/inflamm drugs, init |
T49.1X5A |
Adverse effect of antipruritics, initial encounter |
T49.2X5A |
Adverse effect of local astringents/detergents, init |
T49.3X5A |
Adverse effect of emollients, demulcents and protect, init |
T49.4X5A |
Adverse effect of keratolyt/keratplst/hair trmt drug, init |
T49.5X5A |
Adverse effect of opth drugs and preparations, init |
T49.6X5A |
Adverse effect of otorhino drugs and preparations, init |
T49.7X5A |
Adverse effect of dental drugs, topically applied, init |
T49.8X5A |
Adverse effect of other topical agents, initial encounter |
T49.95XA |
Adverse effect of unspecified topical agent, init encntr |
T50.0X5A |
Adverse effect of mineralocorticoids and their antag, init |
T50.1X5A |
Adverse effect of loop diuretics, initial encounter |
T50.2X5A |
Advrs eff of crbnc-anhydr inhibtr, benzo/oth diuretc, init |
T50.3X5A |
Adverse effect of electrolytic/caloric/wtr-bal agnt, init |
T50.4X5A |
Adverse effect of drugs affecting uric acid metabolism, init |
T50.5X5A |
Adverse effect of appetite depressants, initial encounter |
T50.6X5A |
Adverse effect of antidotes and chelating agents, init |
T50.7X5A |
Adverse effect of analeptics and opioid receptor antag, init |
T50.8X5A |
Adverse effect of diagnostic agents, initial encounter |
T50.995A |
Adverse effect of drug/meds/biol subst, init |
T50.A15A |
Advrs effect of pertuss vaccine, inc combin w pertuss, init |
T50.A25A |
Adverse effect of mixed bact vaccines w/o a pertuss, init |
T50.A95A |
Adverse effect of other bacterial vaccines, init encntr |
T50.B15A |
Adverse effect of smallpox vaccines, initial encounter |
T50.B95A |
Adverse effect of other viral vaccines, initial encounter |
T50.Z15A |
Adverse effect of immunoglobulin, initial encounter |
T50.Z95A |
Adverse effect of vaccines and biological substances, init |